|Last Price||Today's Change||52-Week Range||Trading Volume|
|32.20||0.00 (0.00%)||21.05 - 39.00||5.8 thousand (Below Avg)|
Market data as of 4:00PM 06/18/13. Quotes are delayed by at least 15 min.
Collaborations, Clinical Development Programs, FDA Approvals, New Treatments and Attractive Product Portfolios - Research Report on Medivation, Acadia, Santarus, Seattle Genetics, and PDL BioPharma
06/10/2013 8:00 AM ET
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
06/02/2013 9:00 AM ET